Forgot password?

L’utilité de ce genre d’institutions est incontestable. Car le monde moderne est sans cesse confronté à des innovations, médicales ou autres, qui s’appliquent à l’homme ou à son environnement proche. Ce lieu est donc nécessaire pour préparer la matière intellectuelle qui sera ensuite transférée aux citoyens afin que ceux- ci puissent se prononcer quant à la légitimité de ces innovations.


Professeur Axel Kahn, le célèbre généticien français, lors de l’inauguration de la Fondation Brocher


Podcasts du Cycle Brocher




Le Cycle Brocher organise de nombreuses conférences au cours de l'année. La plupart des conférences sont disponibles en podcast

Retrouvez les podcasts du Cycle Brocher


Miho Tanaka Miho Tanaka

Senior researcher - Japan Medical Association Research Institute

Japan Medical Association Research Institute

Senior researcher

I work as a senior researcher at the Japan Medical Association Research Institute (JMARI) since 2013. I received my master’s degree (Master of Public Health) from Graduate School of Medicine, The University of Tokyo in 2012. I’m also a member of Medical Ethics and Patient Safety Laboratory, Keio Research Institute at SFC, Keio University. My master thesis’s theme was “An Analysis of the Current State of Pediatric Palliative Care in England”.

My research interests are ethical, social and legal issues around end-of-life care in Japan, other western and Asian countries, including UK, USA, Korea and Taiwan. More recently, my colleagues and I have collaborated internationally on a project “ethical and legal issues around end-of-life care in East Asia. Not only western countries but also several Asian countries, such as Taiwan and Korea, enacted forgoing life-sustaining treatments (LSTs), but Japan has never passed such a law. On the other hands, no countries in Asia legalise euthanasia. In Japan, a slippery slope to vulnerable people, including disabled people and patients with intractable diseases, has been brought out in end-of-life care debate.

I recently published an academic book in Japanese “Choices at the End of Life” in collaboration with my colleague. The book includes contents of thinking about your EOL, PEG in a super-aged society, choosing the treatment options at EOL and letting it be known, care at the Dying Stage, palliative care, should we allow active euthanasia or not, suicide tourism, and withdrawal of LSTs.

I also had worked as a journalist at the newspaper company in 1996-2008. I had reported various themes such as child abuse, domestic violence, long-term care insurance et al.